Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet.

Rats received a choline-deficient diet containing 0.1% (w/w) DL-ethionine (CDE) for 4, 10, 14 or 22 weeks. A separate group was treated for 4 weeks with CDE and then received a normal diet for 4 weeks. The L and M2 isoenzymes of pyruvate kinase were immunocytochemically demonstrated in liver sections. L-PK expression was strongly reduced in the hepatocytes after 4 weeks of treatment and remained low until the end of the study. Withdrawal of CDE after 4 weeks followed by 4 weeks normal diet resulted in a nearly full recovery of L-PK expression as compared to untreated controls. At later stages (10-22 weeks of CDE- treatment) many pseudolobules, preneoplastic foci of altered hepatocytes (FAH) such as combined clear/acidophilic cell foci (CCF/ACF) and mixed/basophilic cell foci (MCF/BCF), and hepatocellular adenomas (HCA) were observed. Pseudolobules showed a slight reduction in L-PK-expression, and were negative for M2-PK. In all clear cell components of CCF/ACF excessively storing glycogen, L-PK-expression was increased compared to both the surrounding parenchyma and hepatocytes of controls. In acidophilic cell components with less pronounced glycogen storage L-PK expression was similar to that of pseudolobules showing a slightly reduced content of this enzyme protein. M2-PK was invariably negative in CCF/ACF. In most MCF glycogen-storing subpopulations expressed L-PK, whereas in all glycogen-poor basophilic populations L-PK protein was strongly reduced. M2-PK was not expressed in most of these MCF. However, in rare MCF the reduction in L-PK expression was combined with a significant expression of M2-PK. In HCA M2-PK underwent a further increase, although to a variable degree, while L-PK remained strongly reduced. Our results show that an isoenzyme shift from L-PK to M2-PK takes place at a late stage of the hepatocarcinogenic process, and that those MCF with a low L-PK expression and a reexpression of M2-PK most probably represent the direct precursor lesions of hepatocellular neoplasms.

[1]  P. Gali,et al.  Immunocytochemical study of pyruvate kinase isoenzymes in normal and pathologic human liver. , 2008, Liver.

[2]  D. Mayer,et al.  Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. , 1984, Advances in enzyme regulation.

[3]  G. Weber.  Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. , 1983, Cancer research.

[4]  A. Kahn.  Transcriptional regulation by glucose in the liver. , 1997, Biochimie.

[5]  P. Walker,et al.  Isozyme studies on adult, regenerating, precancerous and developing liver in relation to findings in hepatomas. , 1972, Advances in enzyme regulation.

[6]  M. Kochman,et al.  Isozyme pattern of pyruvate kinase during hepatocarcino-genesis induced by 2-acetylaminofluorene in rat liver. , 1978, European journal of cancer.

[7]  K. Matsumura,et al.  Isozyme patterns of pyruvate kinase in various primary liver tumors induced during the process of hepatocarcinogenesis. , 1974, Cancer research.

[8]  F. Oesch,et al.  Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. , 1991, Carcinogenesis.

[9]  E. Eigenbrodt,et al.  Chapter 10 – Carbohydrate Metabolism and Neoplasia: New Perspectives for Diagnosis and Therapy , 1994 .

[10]  F. Oesch,et al.  Expression of L- and M2-pyruvate kinases in proliferating oval cells and cholangiocellular lesions developing in the livers of rats fed a methyl-deficient diet. , 1994, Carcinogenesis.

[11]  T. Tanaka,et al.  Members of the nuclear factor 1 family and hepatocyte nuclear factor 4 bind to overlapping sequences of the L-II element on the rat pyruvate kinase L gene promoter and regulate its expression. , 1997, The Biochemical journal.

[12]  F. Oesch,et al.  Persistence of the cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/DL-ethionine-supplemented diet. , 1992, Carcinogenesis.

[13]  D. Mayer,et al.  Hexokinase expression in liver preneoplasia and neoplasia. , 1997, Biochemical Society transactions.

[14]  S. Sell,et al.  Enhancement of DL-ethionine-induced liver carcinogenesis in rats fed a choline-devoid diet. , 1978, Journal of the National Cancer Institute.

[15]  R. Schulte‐Hermann,et al.  Pyruvate kinase isoenzymes in altered foci and carcinoma of rat liver. , 1986, Carcinogenesis.

[16]  D. Mayer,et al.  Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine. , 1984, Carcinogenesis.

[17]  S. Weinhouse.  What are isozymes telling us about gene regulation in cancer? , 1982, Journal of the National Cancer Institute.

[18]  L. Larsson.  Immunocytochemistry: Theory and Practice , 1988 .

[19]  P. Bannasch,et al.  Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis. , 1993, Carcinogenesis.

[20]  C. Post,et al.  Solution structure of a band 3 peptide inhibitor bound to aldolase: a proposed mechanism for regulating binding by tyrosine phosphorylation. , 1995, Biochemistry.

[21]  T. Tanaka,et al.  Transcriptional regulatory regions for expression of the rat pyruvate kinase M gene. , 1994, European journal of biochemistry.

[22]  H. Towle,et al.  Dietary polyunsaturated fatty acids interfere with the insulin/glucose activation of L-type pyruvate kinase gene transcription. , 1994, Molecular endocrinology.

[23]  S. Weinhouse.  Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. , 1972, Cancer research.

[24]  A. Munnich,et al.  Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver. , 1986, The Journal of biological chemistry.

[25]  A. Kahn,et al.  Role of the GLUT 2 Glucose Transporter in the Response of the L-type Pyruvate Kinase Gene to Glucose in Liver-derived Cells* , 1997, The Journal of Biological Chemistry.

[26]  P. Bannasch.  Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. , 1996, Progress in liver diseases.

[27]  G. Staal,et al.  Pyruvate Kinase in Selected Human Tumors , 1991 .

[28]  S. C. Garner,et al.  Effects of prolonged (1 year) choline deficiency and subsequent re-feeding of choline on 1,2-sn-diradylglycerol, fatty acids and protein kinase C in rat liver. , 1995, Carcinogenesis.

[29]  M. Gumińska,et al.  Electrophoretic pattern of cytosolic pyruvate kinase fractions A and B (type L and M2) from normal rat liver and Morris hepatoma 7777. , 1996, Biochimica et biophysica acta.

[30]  E. Newsholme,et al.  Application of metabolic-control logic to fuel utilization and its significance in tumor cells. , 1991, Advances in enzyme regulation.

[31]  H. Morris,et al.  COMPARATIVE BIOCHEMISTRY OF HEPATOMAS. III. CARBOHYDRATE ENZYMES IN LIVER TUMORS OF DIFFERENT GROWTH RATES. , 1963, Cancer research.

[32]  H. Zerban,et al.  Foci of Altered Hepatocytes, Rat , 1997 .

[33]  E. Eigenbrodt,et al.  Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-Pk) in tumors of chicken and rat , 1981, Virchows Archiv. B, Cell pathology including molecular pathology.

[34]  E. Eigenbrodt,et al.  Immunohistological demonstration of pyruvate kinase isoenzyme type L in rat with monoclonal antibodies. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  C. Weigert,et al.  Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. , 1997, European journal of biochemistry.

[36]  N. Katz,et al.  Immunohistochemical demonstration of decreased L-pyruvate kinase in enzyme altered rat liver lesions produced by different carcinogens , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[37]  M. Tatematsu,et al.  Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens. , 1981, Cancer research.

[38]  K. Shinohara,et al.  A new pyruvate kinase variant (PK Osaka) demonstrated by partial purification and condensation. , 1976, American journal of human genetics.

[39]  A. Kopp-Schneider,et al.  Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. , 1994, Carcinogenesis.